Accepted: 18 November 2022
First Online: 24 January 2023
: Ethics approval was generally not applicable as these country assessments were led by the ministries of health as programme assessments and not conducted as research activities. In countries where required, ethics approval was obtained. The information collected during the desk review is publicly available data and the key informants all participated within their official capacity and were selected by the ministries of health. Verbal informed consent to participate in the assessment was obtained from all participants.
: Not applicable as this paper describes a methodological approach to assess availability of MA medicines in countries by using an analytical and conceptual framework.
: The authors declare that they have no competing interests.